ad image

Discovery

1 / 4
MS Society

Myelin Repair Discovery Step Forward in Search to Stop MS

MS Society

PR-M02-22-12Feb 14, 2022
New Insights into Virus Evasion Tactics
Virus

New Insights into Virus Evasion Tactics

Pharma's Almanac

PAO-M00-19-NI-003Sep 04, 2019
Researchers Discover Potential Cause for Alzheimer’s Disease
Research

Researchers Discover Potential Cause for Alzheimer’s Disease

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M11-18-NI-028Nov 28, 2018
NYU Langone Health
Research

Newfound Mechanism May Yield Ways to Counter Mistaken Immune Attack on Body

NYU Langone Health

PR-M11-18-NI-097Nov 28, 2018
CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next
CRISPR

CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next

Nigel Walker

Nice Insight

PAO-M08-18-NI-030Aug 29, 2018
Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719
Clinical Data

Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719

Nice Insight

PAO-M08-18-NI-028Aug 29, 2018
AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment
FDA Approval

AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-18-NI-027Aug 29, 2018
National University of Science and Technology MISiS
Research

A Key to the Cage: Opening the Living Membrane Gate

National University of Science and Technology MISiS

PR-M06-18-NI-066Jun 20, 2018
State-of-the-Art Biologics Manufacturing in an Unexpected Location
GMP

State-of-the-Art Biologics Manufacturing in an Unexpected Location

Vladas Algirdas Bumelis

Northway Biotechpharma

PAP-Q2-18-CL-010May 29, 2018
Challenges for Next-Generation Biological Therapeutics in Discovery and Development
Next-Generation Drug Development

Challenges for Next-Generation Biological Therapeutics in Discovery and Development

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-18-FA-001May 29, 2018
Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services
Fill-Finish Services

Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

Andrea Baiocchi

Avara Pharmaceutical Services

PAP-Q2-18-CL-020May 29, 2018
TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date
Drug Discovery

TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date

Guy Tiene

Nice Insight

PAO-M05-18-NI-020May 29, 2018
A New Landscape: M&A in the Discovery & Research Sector
Discovery

A New Landscape: M&A in the Discovery & Research Sector

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q1-18-NI-002Mar 12, 2018
Fully Supporting Customer Needs for Biologics Development and Manufacturing
Biologics

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Samsung Biologics

PAP-Q1-18-CL-016Mar 12, 2018
Single-Pill, HIV-1 Combination Therapy Approved
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

Nice Insight

PAO-M11-17-NI-050Nov 30, 2017
Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

Nice Insight

PAO-M11-17-NI-049Nov 30, 2017
Advanced Follicular Lymphoma Treatment Approved
FDA Approval

Advanced Follicular Lymphoma Treatment Approved

Nice Insight

PAO-M11-17-NI-048Nov 28, 2017
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
Gene Editing

Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems

Nice Insight

PAO-M11-17-NI-046Nov 28, 2017
SiteOne Therapeutics Garners US Department of Defense Award
Non-Opioid

SiteOne Therapeutics Garners US Department of Defense Award

Emilie Branch

Pharma's Almanac

PAO-M11-17-NI-036Nov 21, 2017
Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy
Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

Nice Insight

PAO-M11-17-NI-020Nov 10, 2017
1 / 4